Sponsored by

Momenta, Mylan plan trial of biosimilar to Regeneron eye drug | Reuters

 Momenta, Mylan plan trial of biosimilar to Regeneron eye drug | Reuters

This story has not been edited by Firstpost staff and is generated by auto-feed.

Your guide to the latest election news, analysis, commentary, live updates and schedule for Lok Sabha Elections 2019 on firstpost.com/elections. Follow us on Twitter and Instagram or like our Facebook page for updates from all 543 constituencies for the upcoming general elections.

Updated Date: Jan 04, 2018 05:00:15 IST

Also See